[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13307 participants.

Also called NCT01994720

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 13,307 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01994720
  • EudraCT 2012-003895-38
Other papers using this trial's data
  • Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial The Lancet. Neurology, 2017-04 DOI, PubMed 28238711
  • Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial International journal of stroke : official journal of the International Stroke Society, 2019-12 DOI, PubMed 31092152
  • Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source Stroke, 2017-09 DOI, PubMed 28720658
  • Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) Stroke, 2017-01 DOI, PubMed 27899747
  • Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack The New England journal of medicine, 2016-07-07 DOI, PubMed 27160892
  • Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial Stroke, 2019-03 DOI, PubMed 30776996 PubMed links an erratum for this paper. Erratum: PMID 30908157

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia, France, Germany, Hong Kong SAR China, Hungary, Israel, Italy, Japan, Mexico, Peru, Philippines, Poland, Romania, Russia, Slovakia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, Ukraine, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01994720. Randomized; double masking; primary purpose prevention. Start 2014-01-07 (actual); primary completion 2016-03-02 (actual). Results posted on 2017-06-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
Acronym
SOCRATES
Condition
Acute Ischaemic Stroke
Condition
Transient Ischaemic Attack
Intervention (Drug)
ticagrelor
Intervention (Drug)
Acetylsalicylic acid (ASA)
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01994720
Content hash
66a58fce8f44590e3815af138b1a7a5dad9fbcec598ca40b82414d3e0af83ab7